TIRO-AF: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Tirzepatide (Primary)
- Indications Atrial fibrillation; Obesity
- Focus Therapeutic Use
- Acronyms TIRO-AF
- 04 Feb 2025 New trial record